N-[(1R)-1-[3-(4-ethylphenyl)-2-pyridinyl]-2-phenylethyl]-2-(5-hydroxy-1H-indol-3-yl)acetamide;N-[(1S)-1-[3-(4-ethylphenyl)-2-pyridinyl]-2-phenylethyl]-2-[3-(trifluoromethyl)-4,5,6,7-tetrahydroindazol-1-yl]acetamide;N-[(1R)-1-[3-(4-ethylphenyl)-2-pyridinyl]-2-phenylethyl]-2-[3-(trifluoromethyl)-4,5,6,7-tetrahydroindazol-1-yl]acetamide;N-[(1S)-2-(3-fluorophenyl)-1-[3-(2-methylphenyl)-2-pyridinyl]ethyl]-2-(5-hydroxy-1H-indol-3-yl)acetamide;N-[(1S)-2-(3-fluorophenyl)-1-[3-(2-methylphenyl)-2-pyridinyl]ethyl]-2-[3-(trifluoromethyl)-4,5,6,7-tetrahydroindazol-1-yl]acetamide
C153H145F11N18O7 — CID 159527373
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-[(1R)-1-[3-(4-ethylphenyl)-2-pyridinyl]-2-phenylethyl]-2-(5-hydroxy-1H-indol-3-yl)acetamide;N-[(1S)-1-[3-(4-ethylphenyl)-2-pyridinyl]-2-phenylethyl]-2-[3-(trifluoromethyl)-4,5,6,7-tetrahydroindazol-1-yl]acetamide;N-[(1R)-1-[3-(4-ethylphenyl)-2-pyridinyl]-2-phenylethyl]-2-[3-(trifluoromethyl)-4,5,6,7-tetrahydroindazol-1-yl]acetamide;N-[(1S)-2-(3-fluorophenyl)-1-[3-(2-methylphenyl)-2-pyridinyl]ethyl]-2-(5-hydroxy-1H-indol-3-yl)acetamide;N-[(1S)-2-(3-fluorophenyl)-1-[3-(2-methylphenyl)-2-pyridinyl]ethyl]-2-[3-(trifluoromethyl)-4,5,6,7-tetrahydroindazol-1-yl]acetamide
N-[(1R)-1-[3-(4-ethylphenyl)-2-pyridinyl]-2-phenylethyl]-2-(5-hydroxy-1H-indol-3-yl)acetamide;N-[(1S)-1-[3-(4-ethylphenyl)-2-pyridinyl]-2-phenylethyl]-2-[3-(trifluoromethyl)-4,5,6,7-tetrahydroindazol-1-yl]acetamide;N-[(1R)-1-[3-(4-ethylphenyl)-2-pyridinyl]-2-phenylethyl]-2-[3-(trifluoromethyl)-4,5,6,7-tetrahydroindazol-1-yl]acetamide;N-[(1S)-2-(3-fluorophenyl)-1-[3-(2-methylphenyl)-2-pyridinyl]ethyl]-2-(5-hydroxy-1H-indol-3-yl)acetamide;N-[(1S)-2-(3-fluorophenyl)-1-[3-(2-methylphenyl)-2-pyridinyl]ethyl]-2-[3-(trifluoromethyl)-4,5,6,7-tetrahydroindazol-1-yl]acetamide (PubChem CID 159527373) has the molecular formula C153H145F11N18O7 and a molecular weight of 2556.94 g/mol. Its IUPAC name is N-[(1R)-1-[3-(4-ethylphenyl)-2-pyridinyl]-2-phenylethyl]-2-(5-hydroxy-1H-indol-3-yl)acetamide;N-[(1S)-1-[3-(4-ethylphenyl)-2-pyridinyl]-2-phenylethyl]-2-[3-(trifluoromethyl)-4,5,6,7-tetrahydroindazol-1-yl]acetamide;N-[(1R)-1-[3-(4-ethylphenyl)-2-pyridinyl]-2-phenylethyl]-2-[3-(trifluoromethyl)-4,5,6,7-tetrahydroindazol-1-yl]acetamide;N-[(1S)-2-(3-fluorophenyl)-1-[3-(2-methylphenyl)-2-pyridinyl]ethyl]-2-(5-hydroxy-1H-indol-3-yl)acetamide;N-[(1S)-2-(3-fluorophenyl)-1-[3-(2-methylphenyl)-2-pyridinyl]ethyl]-2-[3-(trifluoromethyl)-4,5,6,7-tetrahydroindazol-1-yl]acetamide.
Molecular Properties
| Compound Name | N-[(1R)-1-[3-(4-ethylphenyl)-2-pyridinyl]-2-phenylethyl]-2-(5-hydroxy-1H-indol-3-yl)acetamide;N-[(1S)-1-[3-(4-ethylphenyl)-2-pyridinyl]-2-phenylethyl]-2-[3-(trifluoromethyl)-4,5,6,7-tetrahydroindazol-1-yl]acetamide;N-[(1R)-1-[3-(4-ethylphenyl)-2-pyridinyl]-2-phenylethyl]-2-[3-(trifluoromethyl)-4,5,6,7-tetrahydroindazol-1-yl]acetamide;N-[(1S)-2-(3-fluorophenyl)-1-[3-(2-methylphenyl)-2-pyridinyl]ethyl]-2-(5-hydroxy-1H-indol-3-yl)acetamide;N-[(1S)-2-(3-fluorophenyl)-1-[3-(2-methylphenyl)-2-pyridinyl]ethyl]-2-[3-(trifluoromethyl)-4,5,6,7-tetrahydroindazol-1-yl]acetamide |
|---|---|
| PubChem CID | 159527373 |
| Molecular Formula | C153H145F11N18O7 |
| Molecular Weight | 2556.94 g/mol |
| Exact Mass | 2555.14 |
| IUPAC Name | N-[(1R)-1-[3-(4-ethylphenyl)-2-pyridinyl]-2-phenylethyl]-2-(5-hydroxy-1H-indol-3-yl)acetamide;N-[(1S)-1-[3-(4-ethylphenyl)-2-pyridinyl]-2-phenylethyl]-2-[3-(trifluoromethyl)-4,5,6,7-tetrahydroindazol-1-yl]acetamide;N-[(1R)-1-[3-(4-ethylphenyl)-2-pyridinyl]-2-phenylethyl]-2-[3-(trifluoromethyl)-4,5,6,7-tetrahydroindazol-1-yl]acetamide;N-[(1S)-2-(3-fluorophenyl)-1-[3-(2-methylphenyl)-2-pyridinyl]ethyl]-2-(5-hydroxy-1H-indol-3-yl)acetamide;N-[(1S)-2-(3-fluorophenyl)-1-[3-(2-methylphenyl)-2-pyridinyl]ethyl]-2-[3-(trifluoromethyl)-4,5,6,7-tetrahydroindazol-1-yl]acetamide |
| SMILES | CCc1ccc(-c2cccnc2[C@@H](Cc2ccccc2)NC(=O)Cc2c[nH]c3ccc(O)cc23)cc1.CCc1ccc(-c2cccnc2[C@@H](Cc2ccccc2)NC(=O)Cn2nc(C(F)(F)F)c3c2CCCC3)cc1.CCc1ccc(-c2cccnc2[C@H](Cc2ccccc2)NC(=O)Cn2nc(C(F)(F)F)c3c2CCCC3)cc1.Cc1ccccc1-c1cccnc1[C@H](Cc1cccc(F)c1)NC(=O)Cc1c[nH]c2ccc(O)cc12.Cc1ccccc1-c1cccnc1[C@H](Cc1cccc(F)c1)NC(=O)Cn1nc(C(F)(F)F)c2c1CCCC2 |
| InChI | InChI=1S/2C31H31F3N4O.C31H29N3O2.C30H28F4N4O.C30H26FN3O2/c2*1-2-21-14-16-23(17-15-21)24-12-8-18-35-29(24)26(19-22-9-4-3-5-10-22)36-28(39)20-38-27-13-7-6-11-25(27)30(37-38)31(32,33)34;1-2-21-10-12-23(13-11-21)26-9-6-16-32-31(26)29(17-22-7-4-3-5-8-22)34-30(36)18-24-20-33-28-15-14-25(35)19-27(24)28;1-19-8-2-3-11-22(19)23-13-7-15-35-28(23)25(17-20-9-6-10-21(31)16-20)36-27(39)18-38-26-14-5-4-12-24(26)29(37-38)30(32,33)34;1-19-6-2-3-9-24(19)25-10-5-13-32-30(25)28(15-20-7-4-8-22(31)14-20)34-29(36)16-21-18-33-27-12-11-23(35)17-26(21)27/h2*3-5,8-10,12,14-18,26H,2,6-7,11,13,19-20H2,1H3,(H,36,39);3-16,19-20,29,33,35H,2,17-18H2,1H3,(H,34,36);2-3,6-11,13,15-16,25H,4-5,12,14,17-18H2,1H3,(H,36,39);2-14,17-18,28,33,35H,15-16H2,1H3,(H,34,36)/t2*26-;29-;25-;28-/m10100/s1 |
| InChIKey | MCOBDBXCKZKKIL-PXJLNJLHSA-N |
| XLogP | 31.57 |
| TPSA | 335.45 Ų |
| H-Bond Donors | 9 |
| H-Bond Acceptors | 18 |
| Rotatable Bonds | 38 |
| Heavy Atoms | 189 |
| Complexity | — |
Lipinski Rule of Five
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2556.94 |
| LogP ≤ 5 | 31.57 |
| H-Bond Donors ≤ 5 | 9 |
| H-Bond Acceptors ≤ 10 | 18 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 159527373 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.